BioTelemetry to pay $44.8M over India testing false claims - Compliance Week
Medical technology company BioTelemetry and its heart rate monitoring subsidiary CardioNet agreed to pay more than $44.8 million to settle allegations they violated U.S. federal health laws by imp...
Read more